Ligand profile
0RJ
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: KP13_32248 — Beta-lactamase SHV-12
Identifiers
Database identifiers and provenance.
- Ligand ID
0RJ- PDB
4mbh- UniProt (this protein)
P0AD64- Target protein
- KP13_32248
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 92.4
- −1 ≤ LogP ≤ 5 -1.86
- MW ≤ 500 Da 132.1
- LogP ≤ 5 -1.86
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 92.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@@H](C(=O)O)N)NC=OC([C@@H](C(=O)O)N)NC=O
InChI=1S/C4H8N2O3/c5-3(4(8)9)1-6-2-7/h2-3H,1,5H2,(H,6,7)(H,8,9)/t3-/m0/s1InChI=1S/C4H8N2O3/c5-3(4(8)9)1-6-2-7/h2-3H,1,5H2,(H,6,7)(H,8,9)/t3-/m0/s1
VJGQHMAKHZCYRV-VKHMYHEASA-NVJGQHMAKHZCYRV-VKHMYHEASA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 0RJ →
- PDB RCSB structure 4mbh →
- UniProt UniProt P0AD64 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “0RJ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32248.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).